"Cardiac MRI Can Aid Researchers In Endpoint Selection For Cardiac Trials" - Darlene Dobkowski
Valentin Fuster, MD, PhD, director of Mount Sinai Heart and physician-in-chief of The Mount Sinai Hospital discusses his recently published recommendations in the Journal of American College of Cardiology regarding cardiac MRI. “MRI is a technology in which limit has not been reached yet. From time to time, experts need to standardize the new uses. In other words, what has happened in the last few years is a complete revolution in the way the methodology is being used. This is what has been done in this document.” He added, “One of the main advices is establishing absolute infarct size as the main outcome measure to assess in the studies evaluating new treatments. Another recommendation is using magnetic resonance scans between days three and seven after the infarction, as this is the period when magnetic resonance parameters are more stable and less affected by rapid changes occurring in the heart as it attempts to repair itself.”
— Valentin Fuster, MD, PhD, Director, Mount Sinai Heart, Physician in Chief, The Mount Sinai Hospital, Professor, Medicine, Cardiology, Icahn School of Medicine at Mount Sinai
